SunTrust Banks Inc. started coverage on shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) in a research report sent to investors on Thursday morning. The firm issued a buy rating on the stock.

Several other equities analysts have also recently weighed in on the stock. Zacks Investment Research cut shares of Ekso Bionics Holdings from a hold rating to a sell rating in a research note on Tuesday, August 2nd. Rodman & Renshaw reaffirmed a buy rating on shares of Ekso Bionics Holdings in a research note on Sunday, July 31st. Finally, B. Riley began coverage on shares of Ekso Bionics Holdings in a research note on Wednesday, September 21st. They set a buy rating and a $8.00 price target for the company.

Ekso Bionics Holdings (NASDAQ:EKSO) traded down 6.2562% during trading on Thursday, reaching $5.6715. 320,484 shares of the company traded hands. The company’s 50-day moving average is $4.37 and its 200 day moving average is $5.40. Ekso Bionics Holdings has a 12 month low of $3.45 and a 12 month high of $10.08. The company’s market cap is $93.19 million.

Ekso Bionics Holdings (NASDAQ:EKSO) last announced its earnings results on Thursday, July 28th. The company reported ($0.61) EPS for the quarter, missing the consensus estimate of ($0.28) by $0.33. On average, analysts anticipate that Ekso Bionics Holdings will post ($1.74) earnings per share for the current year.

5 Day Chart for NASDAQ:EKSO

Receive News & Stock Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related stocks with our FREE daily email newsletter.